The information on this web site is being disclosed for the purposes of AIM Rule 26 and was last updated on 01 October 2019.

Scancell Holdings PLC is an AIM listed company 

Antibody collaboration deal for Scancell

CEO Cliff Holloway tells Proactive London why its antibody collaboration deal is significant and details how it complements Scancell's existing antibody technology. He also explains what is unique about Scancell's antibody pipeline.